about
Genes to diseases (G2D) computational method to identify asthma candidate genesFunctional classes of bronchial mucosa genes that are differentially expressed in asthmaGenome-wide association study reveals two new risk loci for bipolar disorderCharacterization of a common susceptibility locus for asthma-related traitsMucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder populationImmunological and genetic aspects of asthma and allergy.Lack of association of TIM3 polymorphisms and allergic phenotypes.Profiling of differentially expressed genes using suppression subtractive hybridization in an equine model of chronic asthmaAn epigenome-wide association study of total serum immunoglobulin E concentration.Identification of shared risk loci and pathways for bipolar disorder and schizophreniaA Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh SyndromeRole of DNA methylation in expression control of the IKZF3-GSDMA region in human epithelial cells.Meta-analysis identifies seven susceptibility loci involved in the atopic marchGenes Involved in Interleukin-1 Receptor Type II Activities Are Associated With Asthmatic Phenotypes.HLA-DQB1*02 and DQB1*06:03P are associated with peanut allergy.Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder.Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease.Increased Autophagy-Related 5 Gene Expression Is Associated with Collagen Expression in the Airways of Refractory Asthmatics.Pathogenesis of severe asthma.Identification of a new locus at 16q12 associated with time to asthma onset.Antioxidant and anti-inflammatory activities of quercetin 7-O-β-D-glucopyranoside from the leaves of Brasenia schreberi.Genome-wide patterns of identity-by-descent sharing in the French Canadian founder populationAnalyses of associations with asthma in four asthma population samples from Canada and Australia.Distribution of CFTR mutations in Saguenay- Lac-Saint-Jean: proposal of a panel of mutations for population screening.Antioxidant, anti-inflammatory and anticancer activities of methanolic extracts from Ledum groenlandicum Retzius.An epigenome-wide association study of total serum IgE in Hispanic children.DNA methylation signature of interleukin 1 receptor type II in asthma.Tobacco smoke induces changes in IL-1 family in bronchial epithelial cells obtained from asthmatic individuals.Genomic and genealogical investigation of the French Canadian founder population structure.Genetic variation in immune signaling genes differentially expressed in asthmatic lung tissues.Promoter polymorphisms in CHI3L1 are associated with asthma.Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks.Gene set enrichment analysis and expression pattern exploration implicate an involvement of neurodevelopmental processes in bipolar disorder.Origin and spread of a common deletion causing mucolipidosis type II: insights from patterns of haplotypic diversity.The COL5A3 and MMP9 genes interact in eczema susceptibility.The genetics of asthma and allergic diseases: pieces of the puzzle are starting to come together.Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes.X chromosome dosage and presence of SRY shape sex-specific differences in DNA methylation at an autosomal region in human cells.DNA methylation in childhood asthma: an epigenome-wide meta-analysis.Asymptomatic airway hyperresponsiveness: a three-year follow-up.
P50
Q21092184-6817DC82-C393-4DF1-A59B-33FC89979D8EQ24795231-99EC33A4-1D04-4BA9-A05E-9B3E0E9BED86Q28235753-78E6F126-6D28-4E8C-9B51-38509AF53E59Q28255640-2F912245-1D9F-474B-A9F7-F904B8556030Q28264415-D8C296A4-E3AA-46D4-A98C-3D80BD41E1EDQ33350872-358842F4-5242-4766-9138-B94CF6380DD8Q33476560-02256F23-0CF7-4ACF-9DF5-D0468BBA2EA2Q34123695-1FC6C0D9-5D34-40F7-A7F7-951F602CE3D6Q35561353-68994829-D1B7-4A2E-964D-F14DE2FE7B27Q36271840-1015FC3F-C5BB-48E9-A34E-D10133E91514Q36279066-E9920508-A822-481E-86DF-04566EE5389BQ36291642-4E06E412-23B2-416C-B6FF-2476A8307A0DQ36341386-DBC0AE26-F87A-48BD-8F10-50725B0D0901Q37039577-EA5C0C20-3D95-4E74-931B-878CCDFDDC8CQ37186022-8A169B5A-B23A-497D-85E6-4CE7BF501500Q37347628-3D039843-9F62-4D2E-B94E-804788E6F274Q37408201-A3D5B468-FDF1-40B1-A2D7-ED281D65CB0FQ37729501-0135FD8B-3151-4E90-AF38-20267E947C12Q38003659-540FC613-4760-4FF6-B3CE-3D1F7B98A3A9Q39431978-0773ECC6-AAEA-4F14-B415-A94B632BE2DCQ39486365-9309D49F-12F2-4D0E-B369-E794C11573F6Q39670054-51FD8F14-F125-48B1-8052-585A102CDE70Q39999220-EC83D444-7E70-4AC2-A7C0-89EB3F8E3283Q40113300-9C168B53-CEE0-40FC-A15E-C230D8C6F2BCQ40199023-0766A983-EEE6-4B15-BAE0-152F58DACF1DQ40388598-7FC954F3-3DAB-4D5C-B70B-216A9CCC9051Q41833681-828DC66C-1110-4698-8D80-BCDF4FC50D14Q45912605-C067A5AF-EC24-431A-8334-1C8443C58A46Q45985294-ACE7C25E-C1D4-46EF-BF56-649F25664376Q46386896-A7932B0C-5855-4883-888D-573DE969DFE1Q46679047-676B6F6E-F9D3-40DC-801B-81A7C1BD1EB0Q47218106-83090DD1-A1D4-4F18-B9EA-A4FA230F3CE8Q47290653-C9F918DA-3144-4504-8DAE-C25F7FAA1114Q47356672-0F990A3B-94B2-4BCC-BFAB-C1E050A278A0Q47424785-2F8E3770-2740-4354-A24C-3DA4C66665DAQ47707294-03AAA04B-A67C-4214-B559-DB62A319A3F9Q49066089-07B2CC6D-DA0B-4E29-88F3-B1CFE6A64F8BQ49795115-C4D46EAD-E3E6-4F5B-9409-BE0A0BBBDC7DQ50533268-7CBD1ED4-A42A-4E3B-BF39-AF74C69BA564Q50937966-D843BB8A-4828-4425-9893-22DBA794C74F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
C Laprise
@ast
C Laprise
@nl
Catherine Laprise
@en
Catherine Laprise
@es
Catherine Laprise
@ga
type
label
C Laprise
@ast
C Laprise
@nl
Catherine Laprise
@en
Catherine Laprise
@es
Catherine Laprise
@ga
altLabel
C Laprise
@en
C Laprise
@ga
prefLabel
C Laprise
@ast
C Laprise
@nl
Catherine Laprise
@en
Catherine Laprise
@es
Catherine Laprise
@ga
P108
P106
P1153
6603179149
P21
P31
P496
0000-0001-5526-9945